TY - JOUR T1 - Managing COVID-19 in pregnant women JF - Breathe JO - Breathe DO - 10.1183/20734735.0019-2022 VL - 18 IS - 2 SP - 220019 AU - Siara Teelucksingh AU - Melanie Nana AU - Catherine Nelson-Piercy Y1 - 2022/06/01 UR - http://breathe.ersjournals.com/content/18/2/220019.abstract N2 - Pregnant women are no more likely to contract coronavirus disease 2019 (COVID-19) than the background population and two-thirds of those testing positive are asymptomatic [1, 2]. Risk factors for severe infection reflect those outside pregnancy and include being unvaccinated, aged >35 years, having a body mass index >25 kg·m−2, having a medical comorbidity, being in the Black, Asian and Minority Ethnicity (BAME) population, and socioeconomic deprivation [1]. Pregnant women who develop moderate/severe disease are more likely to require hospitalisation and critical care admission, particularly in the third trimester [1].Principles of management of COVID-19 in the general population apply in pregnancy with few exceptions. Clinical inertia can lead to preventable morbidity and mortality. COVID-19 vaccines are safe and should be recommended at any stage of pregnancy. https://bit.ly/3Rj8nWr ER -